Centogene NV (FRA:39K) Accounts Payable & Accrued Expense : €7.04 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Accounts Payable & Accrued Expense?

Centogene NV's quarterly accounts payable & accrued expense increased from Jun. 2022 (€4.88 Mil) to Dec. 2022 (€6.41 Mil) and increased from Dec. 2022 (€6.41 Mil) to Jun. 2023 (€7.04 Mil).

Centogene NV's annual accounts payable & accrued expense declined from Dec. 2020 (€31.79 Mil) to Dec. 2021 (€11.43 Mil) and declined from Dec. 2021 (€11.43 Mil) to Dec. 2022 (€6.41 Mil).

Centogene NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for Centogene NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Accounts Payable & Accrued Expense Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5.44

8.55

31.79

11.43

6.41

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															11.43	6.10	4.88	6.41	7.04

Centogene NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Centogene NV (FRA:39K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (FRA:39K) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CNTG:USA 39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Centogene NV (FRA:39K) Headlines

No Headlines